|
|
ADVERSE REACTIONS
(listed alphabetically, under each subsection)
Allergic Reactions Anaphylactoid reaction, anaphylaxis, angioedema.
Cardiovascular Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction (see WARNINGS), pulmonary edema, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis.
Dermatologic Acne, allergic dermatitis, cutaneous and subcutaneous atrophy, dry scaly skin, ecchymoses and petechiae, edema, erythema, hyperpigmentation, hypopigmentation, impaired wound healing, increased sweating, rash, sterile abscess, striae, suppressed reactions to skin tests, thin fragile skin, thinning scalp hair, urticaria.
Endocrine Decreased carbohydrate and glucose tolerance, development of cushingoid state, glucosuria, hirsutism, hypertrichosis, increased requirements for insulin or oral hypoglycemic adrenocortical and pituitary unresponsiveness (particularly in times of stress, as in trauma, surgery, or illness), suppression of growth in pediatric patients.
Fluid and Electrolyte Disturbances Congestive heart failure in susceptible patients, fluid retention, hypokalemic alkalosis, potassium loss, sodium retention.
Gastrointestinal Abdominal distention, bowel/bladder dysfunction (after intrathecal administration), elevation in serum liver enzyme levels (usually reversible upon discontinuation), hepatomegaly, increased appetite, nausea, pancreatitis, peptic ulcer with possible perforation and hemorrhage, perforation of the small and large intestine (particularly in patients with inflammatory bowel disease), ulcerative esophagitis.
Metabolic Negative nitrogen balance due to protein catabolism.
Musculoskeletal Aseptic necrosis of femoral and humeral heads, calcinosis (following intra-articular or intralesional use), Charcot-like arthropathy, loss of muscle mass, muscle weakness, osteoporosis, pathologic fracture of long bones, postinjection flare (following intra-articular use), steroid myopathy, tendon rupture, vertebral compression fractures.
Neurologic/Psychiatric Convulsions, depression, emotional instability, euphoria, headache, increased intracranial pressure with papilledema (pseudotumor cerebri) usually following discontinuation of treatment, insomnia, mood swings, neuritis, neuropathy, paresthesia, personality changes, psychic disorders, vertigo. Arachnoiditis, meningitis, paraparesis/paraplegia, and sensory disturbances have occurred after intrathecal administration (see WARNINGS, Neurologic section).
Ophthalmic Exophthalmos, glaucoma, increased intraocular pressure, posterior subcapsular cataracts, rare instances of blindness associated with periocular injections.
Other Abnormal fat deposits, decreased resistance to infection, hiccups, increased or decreased motility and number of spermatozoa, malaise, moon face, weight gain.
|
REPORTS OF SUSPECTED CELESTONE SOLUSPAN SIDE EFFECTS / ADVERSE REACTIONS
Below is a sample of reports where side effects / adverse reactions may be related to Celestone Soluspan. The information is not vetted and should not be considered as verified clinical evidence.
Possible Celestone Soluspan side effects / adverse reactions in 48 year old female
Reported by a physician from South Africa on 2011-12-01
Patient: 48 year old female
Reactions: Hypersensitivity, Feeling Hot, Paraesthesia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Celestone Soluspan
Dosage: 2 ml; im
Indication: Inflammation
Start date: 2011-09-13
Celestone Soluspan
Dosage: 2 ml; im
Indication: Carpal Tunnel Syndrome
Start date: 2011-09-13
Possible Celestone Soluspan side effects / adverse reactions in 57 year old female
Reported by a consumer/non-health professional from United States on 2012-02-23
Patient: 57 year old female weighing 90.7 kg (199.6 pounds)
Reactions: Respiratory Rate Increased, Dyspnoea, Dehydration, Heart Rate Increased
Adverse event resulted in: life threatening event
Suspect drug(s):
Celestone Soluspan
|
|
Drug label data at the top of this Page last updated: 2007-11-27
|
|
-- advertisement --
|
